Peer-Reviewed Publication
Prevalence of Pathogenic Germline Variants in Patients With Gastric Cancer Ascertained Through Multigene Panel Testing
June 9, 2025
Study finds that more than 1 in 8 patients with gastric cancer referred for genetic testing harbor pathogenic germline variants in cancer predisposition genes.
Retrospective landscape study of patients tested at Invitae for gastric cancer; higher prevalence than previous estimates supports consideration of germline testing for all gastric cancer patients.
Published in: JCO Precision Oncology